Study the Gauchers Disease Drug Pipeline With New Report
Posted on: Friday, 14 September 2007, 06:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68493) has announced the addition of Genetic Diseases and Dysmorphic Syndromes - Gauchers Disease Drug Pipeline Report to their offering.
"Genetic Diseases and Dysmorphic Syndromes - Gauchers Disease Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of gauchers disease drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Gauchers Disease Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Gauchers Disease Projects
--Top 20 companies in early stage Gauchers Disease Projects
Full Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68493
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Pima County, Arizona Contracts with Motorola to Provide Project 25 Phase 2 TDMA
- Quantum Signs $10.2 Million Phase III Development Contract With Fisker Automotive
- Novatek Launches Second Phase of Development at Yurkharovskoye Field
- Noble Energy Starts Production From Second Phase of Dumbarton Development
- Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
- GO Networks Wins Product Acceptance By U.S. Govt. Rural Development Telecommunications Program
- Targacept Announces Initiation of Phase IIb Development of AZD3480 (TC-1734) for Alzheimer's Disease
- Human Genome Sciences Announces Phase 3 Clinical Development Program for Albuferon(TM) in Chronic Hepatitis C
- Human Genome Sciences Announces Phase 3 Clinical Development Program for LymphoStat-B(TM) in Systemic Lupus Erythematosus
- Advanced Magnetics Announces Design of Phase III Iron Therapy Program for Ferumoxytol
 |
 |
User Comments (0)
RSS Feeds